Showing 1431-1440 of 1635 results for "".
- Innovent Announces NMPA Granted New Indication Approvals for Sulinno for the Treatment of Pediatric Plaque Psoriasis and Noninfectious Uveitishttps://modernod.com/news/innovent-announces-nmpa-granted-new-indication-approvals-for-sulinno-for-the-treatment-of-pediatric-plaque-psoriasis-and-noninfectious-uveitis/2478695/Innovent Biologics announced that Sulinno (adalimumab injection), a recombinant human anti-TNF-α monoclonal antibody drug, has been officially approved by the National Medical Products Administration (NMPA) of China for two new indications, including the treatment
- Nicox’s Licensee Bausch + Lomb Secures Approval of Vyzulta in Colombiahttps://modernod.com/news/nicoxs-licensee-bausch-lomb-secures-approval-of-vyzulta-in-colombia/2478694/Nicox announced that its partner, Bausch + Lomb, has received approval for latanoprostene bunod ophthalmic solution, 0.024% (marketed as Vyzulta In the United States) in Colombia, where it will be marketed under the brand name Cliropta. Vyzulta is currently commercialized in the United Sta
- EU Authorizes First COVID-19 Vaccine With Pfizer, BioNTech’s Comirnatyhttps://modernod.com/news/eu-authorizes-first-covid-19-vaccine-with-pfizer-biontechs-comirnaty/2478691/The European Commission on Monday granted a conditional marketing authorization to Pfizer and BioNTech’s coronavirus vaccine BNT162b2, which will go by the name Comirnaty, with the decision coming mere hours after the Committee for Medicinal Products for Human Use (CHMP) gave its backing fo
- AAO: Leading Advocates for Seniors’ Timely Access to Care Legislation Applaud Senate Bill Introductionhttps://modernod.com/news/aao-leading-advocates-for-seniors-timely-access-to-care-legislation-applaud-senate-bill-introduction/2478675/The Regulatory Relief Coalition (RRC), a group of national physician specialty organizations, announced its strong support for the Improving Seniors’ Timely Access to Care Act, legislation introduced today in the U.S. Senate by Senators Sherrod Brown (D-OH) and John Thune (R-SD). The
- VSY Biotechnology Introduces Protectalon DUO OVD Kithttps://modernod.com/news/vsy-biotechnology-introduces-protectalon-duo-ovd-kit/2478673/VSY Biotechnology has launched Protectalon Duo, which aims to meet OVD needs at different stages of cataract surgery with a single kit. The dual pack contains high filling volume of one unit cohesive (14 mg/mL, 1.1 mL) and one unit dispersive (30 mg/ml, 1.1 ml). “NaHA-based OVDs prov
- Nicox Initiates Phase 2b Trial of NCX 4251, a Potential First-in-Class Treatment for Blepharitishttps://modernod.com/news/nicox-initiates-phase-2b-trial-of-ncx-4251-a-potential-first-in-class-treatment-for-blepharitis/2478662/Nicox SA announced the initiation of the Mississippi trial, a phase 2b clinical trial of NCX 4251, evaluating once-daily dosed NCX 4251 0.1% versus placebo in patients with acute exacerbations of blepharitis. NCX 4251 is a novel patented ophthalmic suspension of fluticasone propionate nanocrystal
- Orbis International Announces Mary Jane Jamar as First Chief Human Resources Officerhttps://modernod.com/news/orbis-international-announces-mary-jane-jamar-as-first-chief-human-resources-officer/2478605/Orbis has named Mary Jane Jamar as the organization’s first Chief Human Resources Officer (CHRO). In this capacity, Ms. Jamar will also join and play a critical role on the Orbis Executive Leadership Team.
- Kodiak Sciences Completes Enrollment of Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet AMDhttps://modernod.com/news/kodiak-sciences-completes-enrollment-of-phase-2b-3-pivotal-study-of-ksi-301-in-patients-with-wet-amd/2478561/Kodiak Sciences announced that recruitment has concluded in its DAZZLE pivotal study of KSI-301, Kodiak’s anti-VEGF antibody biopolymer conjugate, in patients with wet age-related macular degeneration (AMD). DAZZLE was planned to enroll 550 treatment-naïve patients worldwide; the target enr
- Hospitals Hit With Ransomware Attacks as FBI Warns of Escalating Threat to Health Carehttps://modernod.com/news/hospitals-hit-with-ransomware-attacks-as-fbi-warns-of-escalating-threat-to-health-care/2478478/Federal agencies warn that cybercriminals are escalating their extortion attempts against the healthcare sector even as hospitals are facing a nationwide surge in COVID-19 cases, according to a FierceHealthcare
- Nicox’s NCX 470 Receives Approval by Chinese Authorities for Local Start of Mont Blanc Phase 3 Trialhttps://modernod.com/news/nicoxs-ncx-470-receives-approval-by-chinese-authorities-for-local-start-of-mont-blanc-phase-3-trial/2478456/Nicox SA announced that its partner, Ocumension Therapeutics, has received approval from China’s Center for Drug Evaluation of the National Medical Products Administration to carry out the Chinese part of the ongoing Mont Blanc trial, the first phase 3 clinical trial on NCX 470 for the lowering o